Photo: STAT
Health
STAT+: Servier’s $1.55 billion muscular dystrophy drug fails first major test
TL;DR
- Servier reports a surprise setback for a drug being tested for a form of muscular dystrophy that lacks treatment.
Short summary
Our full write-up is on its way. For the complete story, read the original report:
Nov 3, 2026 · Updated 11/3/2026, 9:05:52 PM · Reported with: STAT
Sources (1)
NRI Bytes writes its own articles from the reporting below.
STAT — STAT+: Servier’s $1.55 billion muscular dystrophy drug fails first major testUp next · Health
The internet says you should choose brown bread over white for better health, but here's what a doctor recommends
Read next →
More stories
Health
STAT+: Democrats win power to push back on Trump’s health care moves
1h ago
Health
Democrat Keisha Lance Bottoms becomes first Black woman Governor in U.S.
2h ago
Health
Make your breakfast more heart-friendly with these simple changes to your daily meals, from cutting salt to adding whole fruits
2h ago
Health
Neurologists explain how to use BEFAST method to recognise a stroke, warning signs and risk factors
3h ago
